Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Learn how to use dividends to speed up your debt repayment. Discover ways to boost your finances and achieve your goals quicker.
17,874 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
From a modest doorstep gadget to a powerhouse under AMAZON, Ring’s rise is a landmark case of how bold bets and strat...
Coinbase and Bybit are in early-stage talks about a strategic investment partnership that could pave the way for Bybi...
A single 2019 decision helped Oracle pivot from legacy database vendor to an AI-ready cloud player. This article brea...
Europe’s top AI startups are accelerating moves to the U.S. amid a flood of AI-focused funding. The trend is reshapin...
Anthropic's public listing signals a new wave of AI investment. This piece highlights which major tech names could ri...
A single mobile title is proving that AI hype can’t single-handedly replace human creativity. This billion-dollar bea...
Qualcomm is pivoting from phones to AI chips and software, aiming to blend edge intelligence with data-center power. ...
Blue Origin plans a $10 billion round at a $130 billion valuation, backed by Jeff Bezos and institutional investors. ...
With $1,000 in hand, you can explore high-growth artificial intelligence moonshots. This guide breaks down two potent...
Zscaler is steering its platform toward AI-driven security, aiming to reshape enterprise defense and investor returns...
The United States announced two Section 301 investigations spanning 60 economies, prompting swift Asian responses and...